Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives. Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply.
In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ... FierceBiotech: Grifols, through pioneering plasma research, looks to reveal early warning signs of Parkinson's Grifols, through pioneering plasma research, looks to reveal early warning signs of Parkinson's Yahoo Finance: Health Coalition demands disclosures & end to Grifols’ for-profit blood plasma contract following reports of deaths, harm, non-compliance Health Coalition demands disclosures & end to Grifols’ for-profit blood plasma contract following reports of deaths, harm, non-compliance Spanish drugmaker Grifols SA paid a higher price to buy blood plasma from an entity linked to its controlling family than from third-party suppliers, according to a regulator’s findings submitted in a ... The Hamilton Spectator: Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates
